CAS: 125228-51-5
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacos an-16-yl)-2-hydroxy-2-[2-hydroxy-6-methyl-5-(2-methylbutyl)oxan-2-yl]propanamide REF: 3D-AFA22851CAS: 125228-51-5 | Min. 95% | Nachfragen | Mo 15 Jul 24 |
N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacos an-16-yl)-2-hydroxy-2-[2-hydroxy-6-methyl-5-(2-methylbutyl)oxan-2-yl]propanamide
CAS:125228-51-5
N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.0914]heptacos an-16yl)-2hydroxy 2-[2hydroxy 6methyl 5-(2methylbutyl)oxan 2yl]propanamide is a synthetic cyclic lipopeptide that inhibits the activity …
Formel:
C38H64N8O13
Reinheit:
Min. 95%
Molekulargewicht:
841 g/mol
Ref: 3D-AFA22851
1mg | Nachfragen | |
5mg | Nachfragen | |
10mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 15. Juli 2024